New Distributors Will Ship DNA Samples to
Complete Genomics for Sequencing
MOUNTAIN
VIEW, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM),
the whole human genome sequencing company, today announced that it has signed
four new distributor agreements with well-established Asia-Pacific life
sciences companies — GeneWorks Pty Ltd. In Australia, Cyagen Biosciences in
China, AR Brown Co. Ltd. in Japan, and BML in Korea — to better serve customers
in those regions. These distributors will complement Complete Genomics'
high-quality sequencing by enhancing service accessibility, convenience, and
the efficient delivery of data to its regional customers.
The
dealers bring experience in sample acquisition, handling and management, and
data analysis and bioinformatics. These arrangements will provide Complete
Genomics' customers with sample preparation assistance at the beginning of the
sequencing process and additional data analysis, if required, at the end to
maximize the discovery potential of Complete Genomics' highly accurate data.
"We
are excited to see demand growing for our high-quality sequencing service in
the Asia-Pacific region," said Dan Floerke, director of Market
Development, Asia-Pacific at Complete Genomics. "With the support of our
distributors, our goal is to deliver the best possible service to the customers
in this region by providing easy access to our whole genome sequencing data and
helping to shorten their discovery times."
Complete
Genomics' services provide customers with further insights into the genetic
underpinnings of human diseases, including complex diseases such as cancer. For
the genomes delivered to their customers in the first quarter, the median exome
call rates were above 98 percent and median genome call rates above 96 percent
— both industry-leading metrics. More than 35 percent of the 5,000 genomes that
the company has sequenced to date have been cancer genomes. In addition, when
the allele fraction was 20 percent, Complete Genomics' cancer sequencing
pipeline achieved 92 percent relative sensitivity.
Complete
Genomics is able to support its accuracy claims by publicly releasing the data
for review. In February 2011, Complete Genomics publicly released 60 genomes
and has since updated the data set with an additional 13 genomes, including two
tumor-normal pairs. With this dataset, researchers have access to a
comprehensive collection of small variations in the diversity panel, reporting
of structural variation breakpoints composed into events, and visualization of
genome-wide genomic alterations summarized in Circos plots. In addition, a
number of papers have been published based on this data.
About
Complete Genomics
Complete
Genomics is the whole human genome sequencing company that has developed and
commercialized an innovative DNA sequencing service. The Complete Genomics
Analysis Platform (CGA™ Platform) combines Complete Genomics' proprietary human
genome sequencing technology with advanced informatics and data management
software. Additional information can be found at http://www.completegenomics.com.
Forward-Looking
Statement
Certain
statements in this press release, including with respect to business
opportunities in the Asia-Pacific region, are forward-looking statements that
are subject to risks and uncertainties. These forward-looking statements are
based on management's current expectations, and actual results may differ
materially from our expectations. The following factors, without limitation,
could cause actual results to differ materially from those in our
forward-looking statements actual market growth in the Asia-Pacific region,
customer acceptance of the Company's services, and competitive pressures. More
information on risk factors that could affect our results can be found in our
Quarterly Report on Form 10-Q filed with the SEC on May 9, 2012, including
those listed in that filing under the heading "Risk Factors." We
disclaim any obligation to update information contained in our forward-looking
statements, whether as a result of new information, future events or otherwise.
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Strategy, Investment and Management, focusing Healthcare and Life Science with expertise in ASEAN. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programmes. Many thanks for visiting www.yourvietnamexpert.com and/or contacting us at contact@yourvietnamexpert.com
Dear
Reader,
May I
invite you to visit our new blog: IIMS-Asean http://iims-asean.blogspot.com/
News
and activities of the International Institute of Medicine and Science Asean
Chapter of IIMS, Inc. California, USA - Health care, Life Science, Education,
Research, Philanthropy. Asean is the economic organisation of ten countries
located in South East Asia: Brunei Darussalam, Cambodia, Indonesia, Lao PDR,
Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam. IIMS is a
non-profit organization.
No comments:
Post a Comment